170 людей умерло в Индии от испытаний лекарств
"A Madhya Pradesh state government probe found that six doctors had violated ethical standards in gaining patients' consent for participation in drug trials and did not compensate those who suffered adverse side effects in 76 drug trials on 3,300 patients since 2006, according to results released last June.
..."The consent form that Geete signed said the medicines were part of a study. "I was so stressed about my wife's health, I said OK, OK to everything and signed on the form. We never questioned the doctor, we trusted him blindly," Geete said about his wife, who was a singer. "She became bedridden and stopped speaking or hearing us. She became a vegetable."
Across India, 1700 people who participated in clinical drug trials died between 2007 and 2010, the government's drug regulatory agency said, although no autopsies were carried out to determine the causes of the deaths. In 2010, 22 families of the dead were compensated by U.S. and European drug companies, ranging from $2,000 to $20,000.
Clinical drug trials in 2010 generated business worth $300 million in India, according to the Confederation of Indian Industry. Conducting drug trials here saves the companies almost 40 percent of the total cost of drug development because health-care professionals are cheaper and liability is not very high, analysts said."
Read more: http://www.heraldextra.com/news/world/india-s-spike-in-drug-trials-raises-questions/article_fb2e8da3-8de0-5472-a7fc-6fc8162e661d.html#ixzz1oMnB151Q
..."The consent form that Geete signed said the medicines were part of a study. "I was so stressed about my wife's health, I said OK, OK to everything and signed on the form. We never questioned the doctor, we trusted him blindly," Geete said about his wife, who was a singer. "She became bedridden and stopped speaking or hearing us. She became a vegetable."
Across India, 1700 people who participated in clinical drug trials died between 2007 and 2010, the government's drug regulatory agency said, although no autopsies were carried out to determine the causes of the deaths. In 2010, 22 families of the dead were compensated by U.S. and European drug companies, ranging from $2,000 to $20,000.
Clinical drug trials in 2010 generated business worth $300 million in India, according to the Confederation of Indian Industry. Conducting drug trials here saves the companies almost 40 percent of the total cost of drug development because health-care professionals are cheaper and liability is not very high, analysts said."
Read more: http://www.heraldextra.com/news/world/india-s-spike-in-drug-trials-raises-questions/article_fb2e8da3-8de0-5472-a7fc-6fc8162e661d.html#ixzz1oMnB151Q